OKLO CFO’s Insider Trades Show Confidence Amid SPAC Regulatory Surge
OKLO Inc.’s CFO insider trades reveal a strategic mix of low‑cost purchases and high‑price sales, illustrating disciplined liquidity management and confidence in the SPAC‑biotech merger landscape.
4 minutes to read








